Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Measurement of endothelial function and its clinical utility for cardiovascular risk Al-Qaisi M; Kharbanda RK; Mittal TK; Donald AEVasc Health Risk Manag 2008[]; 4 (3): 647-52Over the past two decades, the central role of the endothelium in the initiation, progression, and clinical sequelae of atherosclerosis has been increasingly recognized. Assessment of the pathobiology of the endothelium and its ability to act as a potential therapeutic target remains an area of active research interest. Whilst endothelial function has been shown to be a marker for risk of cardiovascular events in high-risk groups, there remains considerable debate about the most appropriate way to assess this. We discuss the different clinical methods to assess endothelial function, focusing on flow-mediated dilatation (FMD) of the brachial artery, highlighting the importance of using a standardized methodology, as well as discussing the clinical limitations of using FMD in individuals.|*Laser-Doppler Flowmetry[MESH]|Atherosclerosis/physiopathology[MESH]|Brachial Artery/physiopathology[MESH]|Cardiovascular Diseases/*physiopathology[MESH]|Endothelium, Vascular/*physiopathology[MESH]|Humans[MESH]|Regional Blood Flow/physiology[MESH]|Risk Assessment[MESH]|Vasodilation/*physiology[MESH] |